Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.1K
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

62
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
62
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.0K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

69
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Common and rare variant analyses implicate <i>JARID2</i> in cerebral tau deposition.

NPJ dementia·2026
Same author

Does Casting Material Influence the Number of Casts Required Before Achilles Tenotomy in the Ponseti Treatment of Severe Idiopathic Clubfoot?

Journal of clinical medicine·2026
Same author

Polygenic risk in early-onset coronary artery disease with low prevalence of traditional cardiovascular risk factors.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Proteomic aging clocks in epidemiological studies: advances, applications and prospects.

Nature aging·2026
Same author

Shared proteomic landscape between arteriosclerosis and cardiovascular endpoints: a Mendelian randomization and observational study integrating AlphaFold3 for structural prediction.

Cardiovascular research·2026
Same author

Traumatic brain injury and risk of early-onset dementia: A population-based cohort study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Mar 3, 2026

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.4K

1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function.

Mathias Gorski1,2, Peter J van der Most3, Alexander Teumer4

  • 1Department of Genetic Epidemiology, University Regensburg, Regensburg, Germany.

Scientific Reports
|April 29, 2017
PubMed
Summary

Using denser genetic data, researchers identified 10 new kidney function-associated loci missed by previous genome-wide association studies (GWAS). This improves understanding of kidney development and metabolism pathways.

More Related Videos

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.4K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Related Experiment Videos

Last Updated: Mar 3, 2026

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
05:46

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue

Published on: June 9, 2020

4.4K
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.4K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Area of Science:

  • Genetics
  • Nephrology
  • Genomics

Background:

  • Genome-wide association studies (GWAS) have identified over 50 loci linked to kidney function using common variants.
  • Previous GWAS relied on HapMap imputation, potentially missing novel loci due to incomplete variant catalogs.

Purpose of the Study:

  • To investigate the value of using more complete variant reference sets for imputation in GWAS.
  • To identify novel genetic loci associated with kidney function that were missed by HapMap-based GWAS.

Main Methods:

  • Conducted a GWAS meta-analysis of estimated glomerular filtration rate (eGFR) in 110,517 European ancestry participants.
  • Utilized 1000 Genomes project data for imputation, offering a more comprehensive variant catalog.
  • Performed pathway analysis on identified genes and enriched gene sets.

Main Results:

  • Identified 10 novel loci associated with kidney function (p < 5×10⁻⁸) missed by HapMap-based GWAS.
  • Six novel loci were tagged by common SNPs unique to the 1000 Genomes reference panel.
  • Pathway analysis revealed 39 significant genes and 127 enriched gene sets, including those involved in kidney development and metabolism.

Conclusions:

  • Re-imputing GWAS data from denser reference panels significantly increases the discovery of novel kidney function-associated loci.
  • The identified novel genes are implicated in critical pathways such as kidney development, carbohydrate, and glucose metabolism.
  • This approach enhances genetic discovery for kidney function until whole-genome sequencing is feasible in large populations.